Tumor cell‐specific cytotoxicity by targeting cell cycle checkpoints
Open Access
- 3 June 2003
- journal article
- fj express-summaries
- Published by Wiley in The FASEB Journal
- Vol. 17 (11) , 1-21
- https://doi.org/10.1096/fj.02-1003fje
Abstract
Cell cycle checkpoints act to protect cells from external stresses and internal errors that would compromise the integrity of the cell. Checkpoints are often defective in cancer cells. Drugs that tar...Keywords
Funding Information
- National Health and Medical Research Council
- Australian Research Council
This publication has 31 references indexed in Scilit:
- Histone-deacetylase inhibitors: novel drugs for the treatment of cancerNature Reviews Drug Discovery, 2002
- Histone deacetylases and cancer: causes and therapiesNature Reviews Cancer, 2001
- Histone deacetylases induce angiogenesis by negative regulation of tumor suppressor genesNature Medicine, 2001
- The ins and outs of nucleosome assemblyCurrent Opinion in Genetics & Development, 2001
- 25 years after the nucleosome model: chromatin modificationsTrends in Biochemical Sciences, 2000
- Histone Deacetylase Inhibitors Trigger a G2 Checkpoint in Normal Cells That Is Defective in Tumor CellsMolecular Biology of the Cell, 2000
- Mechanism-Based Target Identification and Drug Discovery in Cancer ResearchScience, 2000
- Duplication and Maintenance of Heterochromatin DomainsThe Journal of cell biology, 1999
- Anti-tumour activity in vitro and in vivo of selective differentiating agents containing hydroxamateBritish Journal of Cancer, 1999
- Cell Cycle Checkpoints: Preventing an Identity CrisisScience, 1996